Sabra Health Care REIT Inc. (SBRA)

Sabra Health Care REIT Inc. (SBRA $17.82)
- $17.82 P/E (TTM): 22.38X Cap: $4.33B
- View SBRA Profile
- View Questions on SBRA

{tplLang.businessdescription | toLang tLang}

{ profileData.description }

{tplLang.details | toLang tLang}

{tplLang.ceo | toLang tLang}

{profileData.profile.details.ceo}

{tplLang.employees | toLang tLang}

{profileData.profile.details.employees | numeraljs '0,0'}

{tplLang.issuetype | toLang tLang}

{profileData.profile.details.issuetype | asIssueType}

{tplLang.industryclassifications | toLang tLang}

{tplLang.sector | toLang tLang}

{profileData.profile.classification.sector}

{tplLang.industry | toLang tLang}

{profileData.profile.classification.industry}

{tplLang.toolname| toLang tLang}

There is no {tplLang.toolname| toLang tLang} currently available for {data.symbolstring}.

Sabra Health Care REIT Inc. (SBRA $17.82)
- $17.82 P/E (TTM): 22.38X Cap: $4.33B
- View SBRA Profile
- View Questions on SBRA

Q: Thoughts on SBRA?

Read Answer Asked by Carla on September 11, 2025

Gilead Sciences Inc. (GILD $119.79)
- $119.79 P/E (TTM): 23.56X Cap: $146.96B
- View GILD Profile
- View Questions on GILD
Intuitive Surgical Inc. (ISRG $534.28)
- $534.28 P/E (TTM): 74.87X Cap: $189.99B
- View ISRG Profile
- View Questions on ISRG
AbbVie Inc. (ABBV $218.04)
- $218.04 P/E (TTM): 107.72X Cap: $403.12B
- View ABBV Profile
- View Questions on ABBV
Johnson & Johnson (JNJ $188.87)
- $188.87 P/E (TTM): 19.96X Cap: $455.29B
- View JNJ Profile
- View Questions on JNJ
Eli Lilly and Company (LLY $862.86)
- $862.86 P/E (TTM): 53.17X Cap: $799.28B
- View LLY Profile
- View Questions on LLY
Medtronic plc. (MDT $90.70)
- $90.70 P/E (TTM): 25.34X Cap: $116.68B
- View MDT Profile
- View Questions on MDT
Stryker Corporation (SYK $356.24)
- $356.24 P/E (TTM): 48.95X Cap: $141.06B
- View SYK Profile
- View Questions on SYK
Thermo Fisher Scientific Inc (TMO $567.39)
- $567.39 P/E (TTM): 32.29X Cap: $210.03B
- View TMO Profile
- View Questions on TMO
Health Care Select Sector SPDR (XLV $144.25)
- $144.25 P/E (TTM): 23.15X Cap: $36.45B
- View XLV Profile
- View Questions on XLV
iShares U.S. Medical Devices ETF (IHI $60.19)
- $60.19 P/E (TTM): 27.92X Cap: $4.15B
- View IHI Profile
- View Questions on IHI
Sabra Health Care REIT Inc. (SBRA $17.82)
- $17.82 P/E (TTM): 22.38X Cap: $4.33B
- View SBRA Profile
- View Questions on SBRA
Healthcare Realty Trust Incorporated (HR $17.72)
- $17.72 Cap: $6.56B
- View HR Profile
- View Questions on HR
iShares U.S. Pharmaceuticals ETF (IHE $75.97)
- $75.97 P/E (TTM): 19.9X Cap: $603M
- View IHE Profile
- View Questions on IHE
Catalyst Pharmaceuticals Inc. (CPRX $21.27)
- $21.27 P/E (TTM): 12.73X Cap: $2.56B
- View CPRX Profile
- View Questions on CPRX

Q: There was an article in the Globe and Mail today by David Rosenberg about the aging population and he suggested health care related investments such as health care REITS, pharma, devices, and services. What do you think of this idea and can you give me a few recommendations in canada and the US for each of the 4 categories (health reits, pharma, devices, sefrvices)? A mix of ETFS and individual stocks would be great.

Read Answer Asked by Carla on July 08, 2025

Sienna Senior Living Inc. (SIA $19.14)
- $19.14 P/E (TTM): 47.5X Cap: $1.73B
- View SIA Profile
- View Questions on SIA
Sabra Health Care REIT Inc. (SBRA $17.82)
- $17.82 P/E (TTM): 22.38X Cap: $4.33B
- View SBRA Profile
- View Questions on SBRA

Q: Hi, what do you think of Sabra Healthcare REIT (SBRA) for aging US population? How does it compare to CSH and Sienna in Canada? Is timing OK with forecasted 3 rate changes in US this year? Other better suggestions for aging US population?

Read Answer Asked by Kel on January 09, 2018